ITRM920099A0 - Antigene 90k associtato a tumori. - Google Patents

Antigene 90k associtato a tumori.

Info

Publication number
ITRM920099A0
ITRM920099A0 IT92RM99A ITRM920099A ITRM920099A0 IT RM920099 A0 ITRM920099 A0 IT RM920099A0 IT 92RM99 A IT92RM99 A IT 92RM99A IT RM920099 A ITRM920099 A IT RM920099A IT RM920099 A0 ITRM920099 A0 IT RM920099A0
Authority
IT
Italy
Prior art keywords
tumors
antigen associated
antigen
Prior art date
Application number
IT92RM99A
Other languages
English (en)
Inventor
Stefano Iacobelli
Clara Natoli
Original Assignee
Uni Degli Studi G D Annunzio C
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi G D Annunzio C, Univ New York filed Critical Uni Degli Studi G D Annunzio C
Publication of ITRM920099A0 publication Critical patent/ITRM920099A0/it
Priority to ITRM920099A priority Critical patent/IT1264490B/it
Priority to AU36290/93A priority patent/AU3629093A/en
Priority to PCT/EP1993/000379 priority patent/WO1993017119A2/en
Priority to IL104745A priority patent/IL104745A0/xx
Priority to PCT/EP1993/000385 priority patent/WO1993016181A1/en
Priority to ZA931100A priority patent/ZA931100B/xx
Priority to AU34979/93A priority patent/AU3497993A/en
Priority to CN93101808A priority patent/CN1076629A/zh
Publication of ITRM920099A1 publication Critical patent/ITRM920099A1/it
Application granted granted Critical
Publication of IT1264490B publication Critical patent/IT1264490B/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ITRM920099A 1992-02-17 1992-02-17 Antigene 90k associato a tumori. IT1264490B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITRM920099A IT1264490B (it) 1992-02-17 1992-02-17 Antigene 90k associato a tumori.
AU36290/93A AU3629093A (en) 1992-02-17 1993-02-16 A 90K tumor-associated antigen, IR-95
PCT/EP1993/000379 WO1993017119A2 (en) 1992-02-17 1993-02-16 A 90k tumor-associated antigen, ir-95
IL104745A IL104745A0 (en) 1992-02-17 1993-02-16 90k tumor-associated antigen,method for the preparation thereof and pharmaceutical compositions containing the same
PCT/EP1993/000385 WO1993016181A1 (en) 1992-02-17 1993-02-17 A 90k tumor-associated antigen, ir-95
ZA931100A ZA931100B (en) 1992-02-17 1993-02-17 A 90K tumor-associated antigen, IR-95.
AU34979/93A AU3497993A (en) 1992-02-17 1993-02-17 A 90K tumor-associated antigen, IR-95
CN93101808A CN1076629A (zh) 1992-02-17 1993-02-17 90k肿瘤相关抗原ir-95的遗传序列

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920099A IT1264490B (it) 1992-02-17 1992-02-17 Antigene 90k associato a tumori.

Publications (3)

Publication Number Publication Date
ITRM920099A0 true ITRM920099A0 (it) 1992-02-17
ITRM920099A1 ITRM920099A1 (it) 1993-08-17
IT1264490B IT1264490B (it) 1996-09-24

Family

ID=11400690

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920099A IT1264490B (it) 1992-02-17 1992-02-17 Antigene 90k associato a tumori.

Country Status (6)

Country Link
CN (1) CN1076629A (it)
AU (2) AU3629093A (it)
IL (1) IL104745A0 (it)
IT (1) IT1264490B (it)
WO (2) WO1993017119A2 (it)
ZA (1) ZA931100B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012681A1 (en) * 1993-11-05 1995-05-11 New York University Methods relating to ir-95
CN1313603C (zh) * 2004-09-30 2007-05-02 北京大学人民医院 抗人卵巢癌单克隆抗体杂交瘤细胞系及其单克隆抗体和应用
GB2435882A (en) * 2006-03-09 2007-09-12 Bioinvent Int Ab Detection and treatment of mantle cell lymphoma
CN115407063A (zh) * 2021-05-26 2022-11-29 江苏科兴诺生物技术有限公司 一种量子点荧光免疫层析法肿瘤标志物（g3bp）试剂盒及其检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies
IT1239719B (it) * 1990-04-23 1993-11-15 Univ Degli Studi Annunzio Uso dell'anticorpo monoclonale sp-2 nella diagnostica clinica ed il monitoraggio del progredire dell'infezione hiv

Also Published As

Publication number Publication date
CN1076629A (zh) 1993-09-29
WO1993017119A2 (en) 1993-09-02
WO1993016181A1 (en) 1993-08-19
AU3497993A (en) 1993-09-03
IT1264490B (it) 1996-09-24
ZA931100B (en) 1994-08-17
AU3629093A (en) 1993-09-13
IL104745A0 (en) 1993-06-10
ITRM920099A1 (it) 1993-08-17

Similar Documents

Publication Publication Date Title
FI913891A7 (fi) Uusi monoklonaalinen vasta-aine uutta antigeenia vastaan, joka liittyy ihmisen kasvaimiin
NO890115D0 (no) Antigen-antistoff-konjugat.
FI930580L (fi) Tri- och tetravalensiska monopecifika antigen bindande proteiner
NO924279D0 (no) Lyofilisert, monoklonalt antistoffpreparat
DE68914244D1 (de) Monoklonaler Antikörper.
DE69018801D1 (de) Chimärischer anti-cae-antikörper.
FI920194A7 (fi) Hexacyklisk foerening.
NO941781D0 (no) Ikke-radioaktiv immunanalyse
DK666389D0 (da) Monoklonalt antistof
DE3879452D1 (de) Chimaere antikoerper.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
DE68917768D1 (de) Einsteckbare Klammer mit innenliegendem Mechanismus.
NO902870L (no) Boeyd motorhus for anvendelse i et borehull.
DE58901418D1 (de) Kraftstoffleitung.
DK190889D0 (da) Antigen
FI895287A7 (fi) Fukosyylikeramidin vastainen monoklonaalinen vasta-aine
ITRM920100A0 (it) Sequenze genetiche per l'antigene 90k associato a tumori.
ITRM920099A0 (it) Antigene 90k associtato a tumori.
NO890116L (no) Monoklonale antistoffer.
FI924576L (fi) Ctaa 28a32, antigen identiefierad av mca 28a32
DK474189A (da) Monoklonalt antistof
DE68910956D1 (de) Mit toxin modifizierter antikörper.
FR2653536B1 (fr) Tube radiant a modules internes.
IT8821702A0 (it) Nuovo anticorpo monoclonale.
DE69023717D1 (de) Monoklonaler Antikörper.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960412